Q32 Bio completes enrollment in SIGNAL-AD clinical trial
PremiumThe FlyQ32 Bio completes enrollment in SIGNAL-AD clinical trial
4M ago
Q32 Bio to join Russell 3000 Index
Premium
The Fly
Q32 Bio to join Russell 3000 Index
4M ago
Verve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
Premium
The Fly
Verve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
4M ago
Q32 Bio Inc. Faces New Financial Hurdles as Increased Regulatory Compliance Looms
PremiumCompany AnnouncementsQ32 Bio Inc. Faces New Financial Hurdles as Increased Regulatory Compliance Looms
6M ago
Q32 Bio reports Q1 EPS ($6.33), consensus ($2.32)
Premium
The Fly
Q32 Bio reports Q1 EPS ($6.33), consensus ($2.32)
6M ago
Q32 Bio files to sell 1.68M shares of common stock for holders
Premium
The Fly
Q32 Bio files to sell 1.68M shares of common stock for holders
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100